Contents:

SECTION ONE: HISTORICAL ASPECTS.

1. Gametes and Embryo Donation: An Evolving Medical Contribution to Human Procreation

SECTION TWO: INDICATIONS.

2. Can we Define the Indications for Oocyte Donation?

3. Treatment of Ovarian Failure.

4. Is Donor Egg IVF a Rational Treatment for Genetic Disorders?

5. Reversing the Natural Decline in Human Fertility with Oocyte Donation to Women of Advanced Reproductive Age

SECTION THREE: FACTORS DEFINING SUCCESS.

6. Do Recipient Age and Infertility Diagnosis Affect Pregnancy and Implantation Rates in a Donor Egg IVF Program?

7. Donor Age is Paramount to Success in Oocyte Donation

8. Importance of Transfer and Uterine Factors in a Donor Egg IVF Program.

9. Do Hydrosalpinges Adversely Affect Implantation in Donor Oocyte Cycles?

10. The Effect of Prior Gravidity on the Outcomes of Egg Donation

11. Factors that Determine Discordant Outcomes from Shared Oocytes

12. Blastocyst Culture and Transfer in Oocyte Donation

13. Endometriosis and Oocyte Donation

14. The Best Donor.

15. Clinical Factors Interfering with Endometrial Receptivity.SECTION FOUR: OOCYTE SHARING PROGRAMS.

16. The Shared Donor Oocyte Program: Advantages and Insights.(Egg Recipients Sharing Oocytes from Single Donor).

17. Egg Recipients Sharing Oocytes from Patients Undergoing IVF

18. Does Egg Sharing Compromise the Chances of Donors or Recipients Achieving a Livebirth?

SECTION FIVE: FINANCIAL CONSIDERATIONS.

19. Social and Financial Aspects of Egg-sharing versus Professional Egg Donation

in a Donor Egg IVF Program

20. Eggs for Sale: How Much is Too Much?

21. Subsidized IVF: Egg-sharing as a Source of Donor Eggs

SECTION SIX: DONOR SCREENING.

22. Oocyte Donor Screening: The Selection Process and Cost Analysis.

23. Genetic Screening of Prospective Oocyte Donors

24. Should Donor Egg IVF Programs Accept PCOS Women as Donors?.SECTION SEVEN: POTENTIAL DONORS.

25. Family Members as Gamete Donors and Surrogates

26. Sisters of Women with Premature Ovarian Failure may not be Ideal Ovum Donors

27. Should Nonpatient Volunteers Donate Eggs?

SECTION EIGHT: ASSESSING ENDOMETRIAL RECEPTIVITY.

28. Endometrial Receptivity in Oocyte Donation Cycles

29. Color and Power Doppler for Assessing Endometrial Receptivity

30. Endometrial TB-PCR: Transcription-mediated Amplification or Histopathology.for Endometrial Evaluation in Donor Egg IVF?

SECTION NINE: ENDOMETRIAL PREPARATION.

31. Preparation of the Endometrium for Egg Donation

32. Long Estradiol Replacement in an Oocyte Donation Program.

33. Vaginal Progesterone Gel Preparation in a Donor Oocyte Program

SECTION TEN: STIMULATION PROTOCOLS FOR OOCYTE DONORS.

34. Role of GnRH Analog Depot Preparations in Donor Egg IVF

35. Long Protocol is the Gold Standard for Ovarian Stimulation in Egg Donors.

36. Timing of Placental Competence in Ovum Donation

SECTION ELEVEN: ULTRASOUND.

37. Role of TVS in Assessing Endometrial and Ovarian Morphology in a Donor Egg IVF Program. Imaging Aspects: A Perspective

38. Upper Genital Tract Screening with Hysterosonography in Patients Receiving Donated Oocytes

SECTION TWELVE: SURROGACY.

39. Surrogacy: Ethical, Psychological and Legal Implications.

40. Gestational Surrogacy.SECTION THIRTEEN: ENDOSCOPY.

41. Role of Hysteroscopy in a Donor Egg IVF Program

SECTION FOURTEEN: COUNSELING

42. Counseling Recipients in a Donor Egg IVF Program

43. Potential Psychological Attachments Formed by Egg Donors Involved in Fertility Technology

SECTION FIFTEEN: ETHICS AND RELIGION.

44. Ethical and Religious Considerations in Third Party Reproduction

SECTION SIXTEEN: OBSTETRICS AND PERINATAL OUTCOMES

45. Factors Influencing the Obstetric and Perinatal Outcomes after Oocyte Donation

46. Pregnancy Results and Obstetric Outcomes in Patients 45 years and Older

SECTION SEVENTEEN: LONG-TERM FOLLOW-UP.

47. Health and Development of Donor Egg IVF Children Compared to IVF Children

SECTION EIGHTEEN: LEGISLATION AND GUIDELINES.

48. Donor Egg IVF: Its Regulation in India

49. Egg-sharing and Policy Making

50. Oocyte Donation: The Legislative Framework in Western Europe

SECTION NINETEEN: WHAT'S NEW?.

51. Oocyte Donation to Human Immunodeficiency Virus-1 Serodiscordant Couples

52. Turner's Syndrome and Oocyte Donation

53. Cross Border or Reproductive Tourism with Special Emphasis on Donor Oocytes.SECTION TWENTY: EPILOGUE.

54. The Internet and Donor Egg IVF

55. Egg Donor: Once Upon a Time-What Will You Tell Them?.

56. Risks of Oocyte Donation

Index